Activated AMPK also boosts Nrf2/HO-1 signaling and suppresses mTOR pathways, promoting autophagy and mitochondrial biogenesis, which helps improve NASH (Figure 3) [61,62]. Here, MTOR is linked to metabolic dysfunction-associated steatohepatitis.